Poređenje dijagnostičkih kriterijuma kod bolesnika sa amiotrofičnom lateralnom sklerozom – doprinos elektromiografskih nalaza

  • Aleksandra Dominović-Kovačević University Hospital Clinical Centre Banja Luka, Clinic of Neurology, Republic of Srpska, Bosnia and Herzegovina
  • Duško Račić University Hospital Clinical Centre Banja Luka, Clinic of Neurology, Republic of Srpska, Bosnia and Herzegovina
  • Sanja Grgić University Hospital Clinical Centre Banja Luka, Clinic of Neurology, Republic of Srpska, Bosnia and Herzegovina
  • Zoran Vukojević University Hospital Clinical Centre Banja Luka, Clinic of Neurology, Republic of Srpska, Bosnia and Herzegovina
  • Sladjan D Milanović University of Belgrade, Institute for Medical Research, Belgrade, Serbia
  • Tihomir V Ilić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia; Military Medical Academy, Clinic of Neurology, Belgrade, Serbia
Ključne reči: amiotrofijska lateralna skleroza;, elektrofiziologija;, elektromiografija;, testovi, prognostička vrednost;, osetljivost i specifičnost.

Sažetak


Uvod/Cilj. Dijagnoza amiotrofične lateralne skleroze (LS) zasniva se na kombinaciji kliničkih znakova i elektro­fizioloških korelata patološkog procesa koji se odvija u osnovi. Novi elektrofiziološki kriterijumi, Awaji-Shima (AS), dodatno kvalifikuju kompleksne fascikulacije i neurogeno izmenjene potencijale motornih jedinica kao znakove aktivnih lezija perifernog motornog neurona, nasuprot ranije važećim revidiranim El Escorial kriterijumima (rEE). Cilj ovog istraživanja bio je da se utvrdi klinički značaj i prednosti primene AS kriterijuma, kod obolelih od ALS. Metode. 30 bolesnika (59,2 ± 10,9 godina, od kojih 57%  sa spinalnom formom bolesti) sa klinički suspektnom ALS, praćeno je od vremena postavljanja dijagnoze do postizanja kategorije definitivne dijagnoze ili smrtnog ishoda. Kod bolesnika su obavljane klinička evaluacija i elektromiografski (EMG) pregledi u tromesečnim intervalima. Rezultati. Primjenom AS kriterijuma, nakon 6 meseci praćenja, kategorija verovatne ili pouzdane dijagnoze postignuta je kod svih bolesnika sa ALS, izuzev jednog (96,6%), nasuprot rEE kriterijuma (33.3%). EMG nalazi bili su pozitivni u ≥ 2 telesna regiona kod 80% bolesnika primenom AS, odnosno 67% primenom rEE. Kompleksne fascikulacije zabeležene su posebno učestalo u malim mišićima stopala (37–40%). Zaključak. Primenom AS kriterijuma kategorija vjerovatne ili pouzdane dijagnoze ALS postiže se za 2,7 meseca ranije, u poređenju sa rEE, na šta posebno utiče veća učestalost pozitivnih EMG nalaza. Ranije utvrđivanje dijagnoze donosi perspektivu veće zastupljenosti obolelih u farmakoterapijskim studijama sa novim terapeutskim agensima.

Reference

REFERENCE

Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007; 369(9578): 2031–41.

Ryberg H, An J, Darko S, Lustgarten JL, Jaffa M, Gopalakrishnan V, et al. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve 2010; 42(1): 104–11.

Lambert EH, Mulder DW. Electromyographic studies in amyotrophic lateral sclerosis. Proc Staff Meet Mayo Clin 1957; 32(17): 441–6.

Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2007; (1): CD001447.

Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1(5): 293–9.

Makki AA, Benatar M. The electromyographic diagnosis of amyotrophic lateral sclerosis: Does the evidence support the El Escorial criteria. Muscle Nerve 2007; 35(5): 614–9.

Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008; 119(3): 497–503.

The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 1996; 53(2): 141–7.

Okita T, Nodera H, Shibuta Y, Nodera A, Asanuma K, Shimatani Y, et al. Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria. J Neurol Sci 2011; 302(1–2): 29–32.

Douglass CP, Kandler RH, Shaw PJ, McDermott CJ. An eva-luation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatr 2010; 81(6): 646–9.

Carvalho MD, Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 2009; 10(1): 53–7.

Noto Y, Misawa S, Kanai K, Shibuya K, Isose S, Nasu S, et al. Awaji ALS criteria increase the diagnostic sensitivity in pa-tients with bulbar onset. Clin Neurophysiol 2012; 123(2): 382–5.

Boekestein WA, Kleine BU, Hageman G, Schelhaas HJ, Zwarts MJ. Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: Retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lat Scler 2010; 11(6): 497–501.

Mills KR. Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome. Brain 2010; 133(11): 3458–69.

Kimura J. Types of electromyographic abnormalities. In: Kimura J, editor. Electrodiagnosis in Diseases of Nerve and Muscle. Principles and Practices. 4th ed. Oxford: Oxford University Press; 2001. p. 339–69.

de Carvalho M, Swash M. Fasciculation potentials: A study of amyotrophic lateral sclerosis and other neurogenic disorders. Muscle Nerve 1998; 21(3): 336–44.

de Carvalho M, Swash M. Fasciculation potentials and earliest changes in motor unit physiology in ALS. J Neurol Neurosurg Psychiatr 2013; 84(9): 963–8.

Schrooten M, Smetcoren C, Robberecht W, van Damme P. Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: A prospective study. Ann Neurol 2011; 70(1): 79–83.

Objavljeno
2020/12/01
Rubrika
Originalni članak